数字农科院2.0

Ubiquitin-conjugating enzyme E2S decreases the sensitivity of glioblastoma cells to temozolomide by upregulating PGAM1 via the interaction with OTUB2

文献类型： 外文期刊

作者： Lin Xu;Baoju Wang;Zhenbo Gang;Zhibin Han;Aowen Wang;Qi Liu;Hongyang Liu;Shilong Wei;Zhiguo Lin;Chuncheng Xie;Li Hu

作者机构：

关键词： GBM;OTUB2;PGAM1;TMZ;UBE2S

期刊名称： International Journal of Biological Macromolecules

ISSN： 0141-8130

年卷期： 2025 年 302 卷

页码：

收录情况： SCIE（2025版） ; ; EI（2025版）

摘要： Background: Glioblastoma (GBM) is an aggressive cancer with limited therapeutic options. Investigating the mechanisms underlying temozolomide (TMZ) resistance and enhancing its sensitivity remain critical for improving GBM treatment outcomes. Ubiquitin-conjugating enzyme E2S (UBE2S) has been implicated in various cancers; however, its role in TMZ resistance in GBM remains unclear. Methods: After UBE2S knockdown, cell viability, apoptosis, and DNA damage were measured in TMZ-treated GBM cells. Immunoprecipitation coupled with mass spectrometry was employed to identify a protein complex involving UBE2S and phosphoglycerate mutase 1 (PGAM1). Co-immunoprecipitation and ubiquitination assays were conducted to examine the interactions among UBE2S, PGAM1, and Otubain-2 (OTUB2). In vivo, a GBM mouse model was used to evaluate the impact of UBE2S knockdown on TMZ efficacy. Results: UBE2S was found to be overexpressed in GBM cells, where it interacts with PGAM1 and OTUB2 to inhibit PGAM1 degradation via K48-linked deubiquitylation. This interaction increased PGAM1 protein levels, promoting DNA repair and reducing apoptosis, thereby decreasing the sensitivity of GBM cells to TMZ. Conclusion: UBE2S plays a critical role in TMZ resistance by stabilizing PGAM1 protein levels through its interaction with OTUB2. Targeting UBE2S represents a promising therapeutic strategy to enhance TMZ efficacy and overcome chemotherapy resistance in GBM.

分类号：

  • 相关文献

[1]UBE2S facilitates glioblastoma progression through activation of the NF-κB pathway via attenuating K11-linked ubiquitination of AKIP1. Zhibin Han,Lin Xu,Aowen Wang,Baoju Wang,Qinfang Liu,Hongyang Liu,Qi Liu,Zhenbo Gang,Shengkun Yu,Long Mu,Changjiang Weng,Zhiguo Lin,Li Hu. 2024

[2]Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy. Li Hu,Xingbo Cheng,Zev Binder,Zhibin Han,Yibo Yin,Donald M. O’Rourke,Sida Wang,Yumeng Feng,Changjiang Weng,Anhua Wu,Zhiguo Lin. 2021

作者其他论文 更多>>